How biotech has managed its finances during the pandemic


The COVID-19 pandemic has had huge knock-on effects on economies around the world.


In this article for European Pharmaceutical Review,  Adrian Toutoungi, Josef Fuss and Matt Caskie of Taylor Wessing explore how the novel coronavirus has hit the life sciences and biotech investment sector and how they see investors behaving as the lockdown and pandemic eases and develops over the next 24 months.

Read the full article first published in European Pharmaceutical Review in Issue #4 2020 on 25 August 2020.

To read more information, click here.

Taylor Wessing is a full-service international law firm, working with clients in the world’s most dynamic industries. We take a single-minded approach to advising our clients, helping them succeed by thinking innovatively about their business issues. We support clients wherever they want to do business. The firm has a sector focus with experts in technology, media and communications, life sciences and private

Taylor Wessing